ISSN:2424-9017
Novel Method of Stem Cell Research on Type I Diabetes
Article Type: Review Article

Sapna A

Cranfield university, Cranfield MK43 0AL, Bedfordshire, UK
Corresponding Author:

Dr. Sapna A

Cranfield university

Cranfield MK43 0AL

Bedfordshire, UK

Received: 2016-01-08 ; Accepted: 2016-01-29 ; Published: 2016-02-05
Citation: Sapna A (2016) Novel Method of Stem Cell Research on Type I Diabetes. J Diab 1:10457.
Copyright: : © 2016 Sapna A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
  • Abstract
  • Full Text
  • References
  • Tables
  • Images
  • PDF

Type I diabetes is a chronic disease especially in children which is mainly identified by loss of beta cells leading to defect in insulin secretion and developing hyperglycaemia. Even though hyperglycemias can be controlled by insulin administration, some insulin injection could not mimic insulin secretion from normal Beta cells in pancreas which are able to the blood glucose levels within the proper range all the time. Hyperglycaemia which is chronic leads to many disorders which is related with diabetic nephropathy and retinopathy.  Treatment includes diet, lifestyle and insulin administration .Pancreas transplantation may be able to treat T1DM (Type 1 Diabetes Mellitus) but there are lacks of organ donors. Many researchers have led to the new innovation treatment which includes cell based therapies to treat T1DM. Novel research has been done on stem cells where embryonic stem cells, pleuripotent cells and tissue cells such as bone marrow, adipose tissues and cord blood derived stem cells. The main object of the review is to summarize the most recently available information regarding T1DM and the use of tissue stem cells to cure T1DM.
Visitor Counter